Glycogen Synthase Kinase 3 (GSK–3) and Its Inhibitors – Drug Discovery and Development : Drug Discovery and Development
Book Details
Format
Hardback or Cased Book
Book Series
Wiley Series in Drug Discovery and Development
ISBN-10
0471770019
ISBN-13
9780471770015
Publisher
John Wiley & Sons Inc
Imprint
Wiley-Interscience
Country of Manufacture
US
Country of Publication
GB
Publication Date
Nov 3rd, 2006
Print length
384 Pages
Weight
658 grams
Dimensions
24.30 x 16.10 x 2.40 cms
Product Classification:
Organic chemistryBiology, life sciences
Ksh 28,050.00
Werezi Extended Catalogue
0 in stock
Delivery Location
Delivery fee: Select location
Secure
Quality
Fast
GSK-3 is a promising drug target that has been extensively tested, and shown great potential for treatment of diseases that have no current effective treatment - like Alzheimer's, bipolar disorder, and cancer.
Many researchers believe that GSK-3 and its inhibitors could lead to effective treatments for neurogenerative disorders, type II diabetes, depression and bipolar disorder, and some forms of cancer. This book provides a thorough introduction to GSK-3, presents up-to-date information, and mentions the birth of several chemical families of GSK-3 inhibitors with varying selectivity. It’s a great reference for researchers in drug design and development.
Get Glycogen Synthase Kinase 3 (GSK–3) and Its Inhibitors – Drug Discovery and Development by at the best price and quality guaranteed only at Werezi Africa's largest book ecommerce store. The book was published by John Wiley & Sons Inc and it has pages.
